What next?
What next?
About this study
There is evidence that shows sensor technology, can be used to help manage older adults’ lung conditions and reduce the number of emergency visits to the hospital. Examples of sensor technology can include finger pulse oximeters, smartwatches, Fitbits, and smart inhalers.
However, we currently don't know which sensor technologies, features and functions are preferred by older adults.
In this project, the researchers want to find out what features and functions of different sensor technology are preferred. This includes the design aspects of the sensor device, as well as how people would like to see their personal health data. This will be explored through an online survey.
The aim of the online survey is to assess the needs and preferences of older adults for self-managing their chronic lung condition using sensor devices.
There are many different types of research. These studies might ask participants to test different treatments, devices, or complete questionnaires. Some studies may not require any involvement from people affected by PF, but instead look at cells in a lab environment, animal models, or utilise computer modelling.
A study involving people can be:
- Interventional – participants are given an active treatment decided by researchers. This could be a change in medication or lifestyle (e.g. exercise, diet, complementary wellbeing therapy, or symptom management). These are commonly known as clinical trials.
- Observational – participants are assessed for specific changes over time, but researchers do not alter their standard treatment or care (e.g. questionnaires to understand the impact of symptom, or patient registries that track trends in how disease affects people or the services that are provided).
There are 3 main phases of clinical trials:
- Phase 1 is the earliest stage of research, where there is often a focus on understanding if the treatment is safe or if it causes any side effects.
- Phase 2 still focuses on safety and side effects, but also tries to find out more about what is the best dose.
- Phase 3 often compares the new treatment to existing treatments or lookalike medications.
As drugs or interventions move into the different phases, the number of people taking part will increase. Not all studies will make it to the later phases, especially if the intervention is not found to be safe or effective in phase 1 and 2.
The recruitment aim is the number of people that researcher want to take part in the research study.
What is involved?
The survey will cover a range of topics, including: demographic information (age, education, gender, ethnicity), details about your lung condition and current management strategies, symptoms and health monitoring practices, familiarity with and preferences for sensor technology, challenges faced in managing your lung condition, information about your carers.
The survey should take approximately 20 minutes to complete.
To take part in this study, please visit the online survey page.
You can save the survey and finish it later, there is no need to complete it all at once.
Summary of involvement
Online survey
Can I take part?
You may be able to take part if you are aged 50 years and over, and are living with a chronic respiratory disease, living in Scotland or England.
In research studies, there are lots of different reasons why you may or may not be able to take part. These are known as inclusion and exclusion criteria (see list below). Only the research team will be able to fully determine whether you are able to take part in the study. You can withdraw at any point.
If you are not able to take part in this research study, there may be other opportunities for you to take part in different studies.
To find out more about other research opportunities visit our research finder main page.
50 years and above
Diagnosis of a chronic respiratory disease
Living in Scotland or England
People who cannot speak or read English language
What difference could taking part make?
The survey may help provide participants with insights into their experiences and allow them to reflect on their self-management strategies, as well as revealing areas where they may need additional support or resources. The participants’ shared experiences will help the research team gain insights that can inform future research, clinical practice and policy decisions related to the management of chronic lung conditions and the preferences and needs for sensor technology.
Where does the study take place?
Study locations
England
Scotland
Online people living in Scotland and England will be able to take part.
How to take part
To take part in the online survey, follow the link here: https://app.onlinesurveys.jisc.ac.uk/s/edinburgh/lungtech1
You can save the survey and finish it later, there is no need to complete it all at once.
Further information
This page is a summary which provides information about an opportunity to participate in research. More detailed information about the study can be found via the following the links and through contacting the research team.
If you have any questions about this research study, please speak to your medical team.
sumetha.kumar@ed.ac.ukThis study is supported by
APF does not endorse or recommend any specific study. All responsibility for the study remains with the sponsors and investigators.
Every effort is made to keep these details up to date. If you are aware of any inaccuracies, please email research@actionpf.org